Tradestie Institutional Equity Comparison Engine

CDIOW vs OABIW โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

OABIW Overall Edge

OABIW Captures Institutional Edge (1โ€“0 Pillars ยท 2โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to OABIW (OABIW) driven by superior Momentum & Technical. Fundamentally, CDIOW trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus OABIW at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, CDIOW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against OABIW sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
CDIOW N/M vs OABIW N/M Fwd P/E
Growth & Margin Winner Tie
Op Margin N/A vs N/A ยท YoY N/A vs N/A
Momentum & Technical Winner OABIW
1Y -58.7% vs +43.9% ยท 52W Pos 1% vs 63%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
CDIOW NASDAQ
Cardio Diagnostics Holdings Inc. Warrant
In Vitro & In Vivo Diagnostic Substances
$0.01
-38.54% 1D
Market Cap N/A
1M Return -41.0%
1Y Return -58.74%
Forward P/E N/M
Unified AI Score
35.2 / 100 SELL
Tech 15.0 Fund 33.0 Flow 50.0 Mom 40.0
OABIW US Equity
OABIW
Institutional Equity
$0.41
-2.38% 1D
Market Cap N/A
1M Return +44.11%
1Y Return +43.86%
Forward P/E N/M
Unified AI Score
49.4 / 100 HOLD
Tech 50.0 Fund 50.0 Flow 50.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CDIOW -58.74% OABIW +43.86% Spread: +159.25 pp (OABIW Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CDIOW TTM Op. Margin: N/A OABIW TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CDIOW vs OABIW. Trailing 12-month operating profitability (CDIOW N/A vs OABIW N/A) and valuation multiples (CDIOW N/M vs OABIW N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CDIOW (1) vs OABIW (2)
Institutional Metric CDIOW OABIW Criterion Row Winner
Market Capitalization Scale N/A N/A Larger Scale Tie
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth N/A N/A Higher Growth Tie
Operating Margin (TTM) Profitability N/A N/A Higher Margin Tie
Net Profit Margin Profitability N/A N/A Higher Margin Tie
Return on Equity (ROE) Capital Efficiency N/A N/A Higher ROE Tie
52-Week Range Position Momentum 1% ($0โ€“$0) 63% ($0โ€“$1) Stronger Trend OABIW
Beta / 30D Volatility Risk Regime 1.59ฮฒ ยท 280% Vol -4.10ฮฒ ยท 376% Vol Lower Realized Risk CDIOW
Unified Institutional Score Composite Signal 35.2 / 100 (SELL) 49.4 / 100 (HOLD) Higher Composite OABIW

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CDIOW vs OABIW Buy Guide
CDIOW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CDIOW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
OABIW UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live OABIW Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CDIOW nor OABIW registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.